Metabolic syndrome raises prostate cancer risk in study

02/28/2014 | Renal and Urology News

Men who had three or more metabolic syndrome components had a 54% greater odds of prostate cancer diagnosis, 56% greater odds of clinically significant PCa and 56% greater odds of intermediate- or high-grade PCa compared with men with no components of metabolic syndrome, data indicated. The findings were published in the journal European Urology.

View Full Article in:

Renal and Urology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC